Vergoeding 2017-2021 voor ATC-subgroep L02AE : Gonadoreline-analogen
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| L02AE01 Busereline (Suprefact ®) | 757.950 | 773.300 | 903.890 | 873.200 | 618.670 |
| L02AE02 Leuproreline (Lucrin pds ®) | 15.245.600 | 15.461.200 | 15.829.700 | 15.527.300 | 12.105.900 |
| L02AE03 Gosereline (Zoladex ®) | 11.797.300 | 12.183.900 | 13.141.800 | 13.352.700 | 12.648.300 |
| L02AE04 Triptoreline (Pamorelin ®) | 2.406.400 | 3.010.200 | 3.692.500 | 4.295.400 | 5.095.300 |
| Totaal | 30.207.250 | 31.428.600 | 33.567.890 | 34.048.600 | 30.468.170 |